485 related articles for article (PubMed ID: 25489073)
21. Cellular redox status determines sensitivity to BNIP3-mediated cell death in cardiac myocytes.
Lee Y; Kubli DA; Hanna RA; Cortez MQ; Lee HY; Miyamoto S; Gustafsson ÅB
Am J Physiol Cell Physiol; 2015 Jun; 308(12):C983-92. PubMed ID: 25810259
[TBL] [Abstract][Full Text] [Related]
22. Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy.
Dhingra R; Rabinovich-Nikitin I; Rothman S; Guberman M; Gang H; Margulets V; Jassal DS; Alagarsamy KN; Dhingra S; Valenzuela Ripoll C; Billia F; Diwan A; Javaheri A; Kirshenbaum LA
Circulation; 2022 Sep; 146(12):934-954. PubMed ID: 35983756
[TBL] [Abstract][Full Text] [Related]
23. Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity.
Fan GC; Zhou X; Wang X; Song G; Qian J; Nicolaou P; Chen G; Ren X; Kranias EG
Circ Res; 2008 Nov; 103(11):1270-9. PubMed ID: 18948619
[TBL] [Abstract][Full Text] [Related]
24. Doxorubicin-induced cardiotoxicity involves IFNγ-mediated metabolic reprogramming in cardiomyocytes.
Ni C; Ma P; Wang R; Lou X; Liu X; Qin Y; Xue R; Blasig I; Erben U; Qin Z
J Pathol; 2019 Mar; 247(3):320-332. PubMed ID: 30426505
[TBL] [Abstract][Full Text] [Related]
25. Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity.
Cui L; Guo J; Zhang Q; Yin J; Li J; Zhou W; Zhang T; Yuan H; Zhao J; Zhang L; Carmichael PL; Peng S
Toxicol Lett; 2017 Jun; 275():28-38. PubMed ID: 28456571
[TBL] [Abstract][Full Text] [Related]
26. Translationally controlled tumor protein (TCTP) plays a pivotal role in cardiomyocyte survival through a Bnip3-dependent mechanism.
Cai W; Fujita T; Hidaka Y; Jin H; Suita K; Shigeta M; Kiyonari H; Umemura M; Yokoyama U; Sadoshima J; Ishikawa Y
Cell Death Dis; 2019 Jul; 10(8):549. PubMed ID: 31320615
[TBL] [Abstract][Full Text] [Related]
27. Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes.
Regula KM; Ens K; Kirshenbaum LA
Circ Res; 2002 Aug; 91(3):226-31. PubMed ID: 12169648
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of doxorubicin-induced cardiac injury by mitochondrial glutaredoxin 2.
Diotte NM; Xiong Y; Gao J; Chua BH; Ho YS
Biochim Biophys Acta; 2009 Feb; 1793(2):427-38. PubMed ID: 19038292
[TBL] [Abstract][Full Text] [Related]
29. Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway.
Danz ED; Skramsted J; Henry N; Bennett JA; Keller RS
Free Radic Biol Med; 2009 Jun; 46(12):1589-97. PubMed ID: 19303434
[TBL] [Abstract][Full Text] [Related]
30. Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy.
Santos DL; Moreno AJ; Leino RL; Froberg MK; Wallace KB
Toxicol Appl Pharmacol; 2002 Dec; 185(3):218-27. PubMed ID: 12498738
[TBL] [Abstract][Full Text] [Related]
31. Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver.
Patel N; Joseph C; Corcoran GB; Ray SD
Toxicol Appl Pharmacol; 2010 Jun; 245(2):143-52. PubMed ID: 20144634
[TBL] [Abstract][Full Text] [Related]
32. Adipocytokine, omentin inhibits doxorubicin-induced H9c2 cardiomyoblasts apoptosis through the inhibition of mitochondrial reactive oxygen species.
Kazama K; Okada M; Yamawaki H
Biochem Biophys Res Commun; 2015 Feb; 457(4):602-7. PubMed ID: 25600813
[TBL] [Abstract][Full Text] [Related]
33. Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.
Oliveira PJ; Bjork JA; Santos MS; Leino RL; Froberg MK; Moreno AJ; Wallace KB
Toxicol Appl Pharmacol; 2004 Oct; 200(2):159-68. PubMed ID: 15476868
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial Targeting of Doxorubicin Eliminates Nuclear Effects Associated with Cardiotoxicity.
Jean SR; Tulumello DV; Riganti C; Liyanage SU; Schimmer AD; Kelley SO
ACS Chem Biol; 2015 Sep; 10(9):2007-15. PubMed ID: 26038829
[TBL] [Abstract][Full Text] [Related]
35. FOXO3a regulates BNIP3 and modulates mitochondrial calcium, dynamics, and function in cardiac stress.
Chaanine AH; Kohlbrenner E; Gamb SI; Guenzel AJ; Klaus K; Fayyaz AU; Nair KS; Hajjar RJ; Redfield MM
Am J Physiol Heart Circ Physiol; 2016 Dec; 311(6):H1540-H1559. PubMed ID: 27694219
[TBL] [Abstract][Full Text] [Related]
36. Doxorubicin-induced thiol-dependent alteration of cardiac mitochondrial permeability transition and respiration.
Oliveira PJ; Santos MS; Wallace KB
Biochemistry (Mosc); 2006 Feb; 71(2):194-9. PubMed ID: 16489925
[TBL] [Abstract][Full Text] [Related]
37. JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure.
Chaanine AH; Jeong D; Liang L; Chemaly ER; Fish K; Gordon RE; Hajjar RJ
Cell Death Dis; 2012 Feb; 3(2):265. PubMed ID: 22297293
[TBL] [Abstract][Full Text] [Related]
38. Bnip3-mediated mitochondrial autophagy is independent of the mitochondrial permeability transition pore.
Quinsay MN; Thomas RL; Lee Y; Gustafsson AB
Autophagy; 2010 Oct; 6(7):855-62. PubMed ID: 20668412
[TBL] [Abstract][Full Text] [Related]
39. Exercise and Doxorubicin Treatment Modulate Cardiac Mitochondrial Quality Control Signaling.
Marques-Aleixo I; Santos-Alves E; Torrella JR; Oliveira PJ; Magalhães J; Ascensão A
Cardiovasc Toxicol; 2018 Feb; 18(1):43-55. PubMed ID: 28536949
[TBL] [Abstract][Full Text] [Related]
40. Bnip3 mediates mitochondrial dysfunction and cell death through Bax and Bak.
Kubli DA; Ycaza JE; Gustafsson AB
Biochem J; 2007 Aug; 405(3):407-15. PubMed ID: 17447897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
